DOI QR코드

DOI QR Code

Mapping Schema Design for Medicine Information Retrieval Based on ATC Code

의약 정보검색을 위한 ATC코드기반 매핑 스키마 설계

  • Kim, Dae-sik (Department of Computer Engineering, Chung-buk National University) ;
  • Kim, Mi-hye (Department of Computer Engineering, Chung-buk National University)
  • Received : 2021.01.26
  • Accepted : 2021.03.20
  • Published : 2021.03.28

Abstract

When using Medical Information Retrieval services, a typical retrieval method is to use the Anatomic Therapyutic Chemical Classification (ATC) code. Traditional ATC code-based medical information retrieval is very useful for single ingredient product retrieval with single ingredient. However, in the case of complex, retrieval errors often occur. The cause of this problem is that ATC code-based retrieval proceeds by pattern matching ATC code.In this work, we design the mapping scheme based on ATC code by analyzing the requirement scenarios for retrieval based on main ingredient in ATC code-based retrieval. the mapping scheme based on ATC is a schema that stores the ATC code of the complex and all the ATC code of the single agent included in the complex. ATC code-based retrieval using this schema retrieves a complex as ingredient of a single ingredient product, thus having higher accuracy than existing methods. the mapping scheme based on ATC is expected to increase the efficiency of doctors' prescription of patients and increase the accuracy of drug safety use services.

의약품 정보검색 서비스를 사용할 때 대표적인 검색방법은 ATC(Anatomic Therapeutic Chemical Classification) 코드를 사용하는 것이다. 기존의 ATC코드 기반 의약정보 검색은 주요 성분이 한가지인 단일제 검색에는 매우 유용하다. 하지만 복합제의 경우에는 검색 오류가 종종 발생하고 있다. 이 문제의 원인은 ATC코드 기반 검색은 단일제 ATC 코드를 패턴매칭하여 진행 된다는 것이다. 본 연구는 ATC코드기반 검색 시 주성분을 기준으로 복합제를 검색하는 요구사항 시나리오를 분석하여 ATC코드기반 매핑 스키마를 설계하였다. ATC코드기반 매핑 스키마는 복합제의 ATC코드와 복합제에 포함된 모든 단일제의 ATC코드를 저장한 스키마를 의미한다. 이 스키마를 사용한 ATC코드기반 검색은 단일제의 주성분으로 복합제를 검색하므로 기존 방법보다 높은 정확도를 가진다. ATC코드기반 매핑 스키마는 의사의 환자 처방 효율을 높일 수 있고 의약품 안전 사용 서비스의 정확도를 올릴 수 있을 것으로 기대된다.

Keywords

References

  1. K. W. Jo & W. Y. Woo. (2005). A Study on the Usage Patterns of Medicine Information Through Web Log Analysis. The Korea Contents Association, 3(2), 269-274.
  2. H. K. Lim et al. (2007), Comparison of WHO-ART Versus MedDRA, Internationally Standardized Terminology of Adverse Drug Reaction Classification. Korean J Clin Pharm, 17(1), 46-52.
  3. S. J. Lee, B. Y. Lee, & I. K, K. (2013). Investigation Study on Gender Difference Based on Korean Data Related to Drug Use. Korean J Clin Pharm. 23(2), 114-122.
  4. K. H. Lim et al. (2017). Analysis of Adverse Drug Reactions in Elderly Patients Based on a Spontaneous Reporting System in a Single Tertiary Hospital. Korean J Med, 92(3), 277-285. https://doi.org/10.3904/kjm.2017.92.3.277
  5. S. M. Kim, H. S. Son, & H. T. Shin. (2011). Drug Prescriptions Comparison Before and After Computerized Drug Utilization Review Program Installation in a Tertiary Hospital Setting. Korean J Clin Pharm. 21(1). 14-21.
  6. S. C Jeong. (2019). Promotion of Adverse Drug Reactions Report through Expansion of Drug Utilization Review. The Korea Contents Association. 19(1), 234-241.
  7. H. Y. Lee, H. S. Choi & E. H. Ji. (2019). The Effects after Implementing a Drug Utilization Review System on Contraindicated Drug use: A Systematic Review. Korean J Clin Pharm, 29(1), 9-17. https://doi.org/10.24304/kjcp.2019.29.1.9
  8. Y. K. Lee, T. J. Lee, Y. J. Park, & S. J. Park. (2004). Policy Measures to Differentiate Drug Insurance Benefits by the Terapeutic Characteristics of Drugs. SeJong: Ministry of Health and Welfare
  9. MFDS Research Department Clinical Research Division. (2011). Introduction to Drug Utilization Research, Cheong ju: Ministry of Food and Drug Safety,
  10. WHO.(1970). ATC., https://www.whocc.no/atc/structure_and_principles/
  11. Korea Pharmaceutical Information Center. (2010). Main component code assignment method, https://www.health.kr/drug_info/basedrug/main_ingredient.html
  12. Health Insurance Review & Assessment Service. (2015). https://opendata.hira.or.kr/op/opc/selectOpenApiInfoView.do
  13. C. J. Lee, (2021). Improving drug licensing by MFDS. Medicalnews.,http://www.newsmp.com/news/articleView.html?idxno=210875
  14. National Legislation Information Center.(2014). Regulations for permission, reporting, and examination of medicines https://www.law.go.kr/LSW/admRulSideInfoP.do?langType=Ko&urlMode=admRulScJoRltInfoR&joChgYn=N&joNo=0002&joBrNo=00&docCls=jo&chrClsCd=010202&admRulSeq=2100000000936
  15. Ministry of Health and Welfa. (2008). Guidelines for marking and managing drug bar codes. https://lawwizice.wordpress.com/2013/02/12/%EC%9D%98%EC%95%BD%ED%92%88%EB%B0%94%EC%BD%94%EB%93%9C-%ED%91%9C%EC%8B%9C-%EB%B0%8F-%EA%B4%80%EB%A6%AC%EC%9A%94%EB%A0%B9%EC%A0%9C2009-150%ED%98%B8-%EB%B3%B4%EA%B1%B4%EB%B3%B5%EC%A7%80%EB%B6%80-20/